Quoin Pharmaceuticals (QNRX) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free QNRX Stock Alerts $0.79 +0.03 (+3.97%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQuoin Pharmaceuticals (QNRX) to Release Earnings on Thursdayamericanbankingnews.com - May 8 at 6:08 AMQuoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024globenewswire.com - May 2 at 4:10 PMQuoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 16 at 7:03 AMMaxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To Knowmarkets.businessinsider.com - March 15 at 4:02 PMQuoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 11:01 AMQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Resultsfinanznachrichten.de - March 14 at 5:29 PMQuoin Pharmaceuticals: Q4 Earnings Insightsbenzinga.com - March 14 at 12:29 PMQuoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Resultsglobenewswire.com - March 13 at 4:05 PMWhy Quoin Pharmaceuticals (QNRX) Shares Are Nosedivingmsn.com - March 7 at 6:55 PMQuoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ETglobenewswire.com - March 7 at 4:05 PMQNRX: Potential Pool of Study Participants Expands; Financial Position Strengthsfinance.yahoo.com - March 6 at 7:49 PMQTI, RNLX and MTC among pre-market losersseekingalpha.com - March 5 at 9:46 AMWhy Is Quoin Pharmaceuticals (QNRX) Stock Down 50% Today?msn.com - March 5 at 9:46 AMQuoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offeringfinance.yahoo.com - March 5 at 9:46 AMQuoin Pharma Shares Double After FDA Grants Clearance for Teens in QRX003 Trialmarketwatch.com - March 4 at 2:31 PMQuoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003markets.businessinsider.com - March 4 at 2:31 PMWhy Quoin Pharmaceutical Stock Is Soaringmsn.com - March 4 at 2:31 PMBuy Rating for Quoin Pharmaceuticals Amid Promising Netherton Syndrome Drug Prospectsmarkets.businessinsider.com - December 15 at 8:05 AMQuoin Pharmaceuticals Ltd ADRmorningstar.com - December 13 at 6:21 PMQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndromefinanznachrichten.de - December 13 at 1:20 PMFDA Clears Quoin Pharma's Protocol Amendments For QRX003 Trials In Netherton Syndrome Treatmentmarkets.businessinsider.com - December 13 at 1:20 PMQNRX: Planned Protocol Modifications Might Accelerate QRX003 Regulatory Approvalfinance.yahoo.com - November 13 at 7:18 PMQuoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 10 at 3:33 PMQuoin Pharmaceuticals Ltd ADR QNRXmorningstar.com - November 10 at 10:33 AMQuoin Pharmaceuticals GAAP EPS of -$7.61 misses by $4.89msn.com - November 9 at 1:25 PMQuoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 8 at 8:25 PMPreview: Quoin Pharmaceuticals's Earningsbenzinga.com - November 7 at 6:44 PMQuoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ETfinance.yahoo.com - November 3 at 3:37 PMQuoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndromefinance.yahoo.com - October 24 at 9:46 AMREPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndromefinance.yahoo.com - October 24 at 9:46 AMQNRX: Positive Early Clinical Data, Moving QRX003 Through Multiple Trialsfinance.yahoo.com - October 2 at 6:27 PMQuoin Pharmaceuticals' Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for Shareholdersfinance.yahoo.com - August 9 at 9:58 AMQuoin Pharmaceuticals Ltd - ADR (QNRX) Price Target Increased by 1423.07% to 134.64msn.com - August 3 at 8:55 AMQuoin Pharmaceuticals Announces Second Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday August 3rd at 8:30 am ETfinance.yahoo.com - July 27 at 8:22 AMWhat's Going On With Quoin Pharmaceuticals (QNRX) Stock Today?benzinga.com - July 21 at 3:34 PMmarketbeat.com - July 21 at 10:03 AMmarketbeat.com - July 21 at 9:54 AMmarketbeat.com - July 21 at 9:51 AMmarketbeat.com - July 21 at 9:35 AMmarketbeat.com - July 18 at 12:28 PMWhy Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today?msn.com - July 17 at 8:58 AMWhy Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today?msn.com - July 17 at 8:58 AMQuoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trialfinance.yahoo.com - May 24 at 8:57 AMQuoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Resultsfinanznachrichten.de - May 12 at 2:48 PMQuoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Resultsfinance.yahoo.com - May 8 at 5:52 PMA Preview Of Quoin Pharmaceuticals's Earningsmsn.com - May 5 at 8:42 PMQuoin Pharmaceuticals Announces First Quarter 2023 Financial Results and Corporate Update Conference Call to Be Held on Tuesday, May 9, 2023 at 8:30 am ETfinance.yahoo.com - May 2 at 8:51 AMQNRX: Patients Dosed in Both Concurrent Studies; Potentially Adding New Assets to Product Portfoliofinance.yahoo.com - March 22 at 5:45 PMQuoin Pharmaceuticals Doses First Patient in Open Label Netherton Syndrome Clinical Trialfinance.yahoo.com - March 21 at 8:36 AMQuoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 11 at 4:04 AM Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now QNRX Media Mentions By Week QNRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QNRX News Sentiment▼0.000.36▲Average Medical News Sentiment QNRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QNRX Articles This Week▼20▲QNRX Articles Average Week Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DYNT News Today TNON News Today NMRD News Today RSLS News Today IONM News Today OSA News Today AEMD News Today BJDX News Today VERO News Today SINT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:QNRX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
